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Background
Resveratrol, a polyphenol mainly present in grapes and red
wine, demonstrated interesting biomedical properties for
its cardioprotective action due to inhibition of the oxida-
tion of low-density lipoprotein (LDL) and of platelet
aggregation, inhibitory effects on cancer promotion and
propagation and anti-inflammatory activities. These poten-
tial therapeutic and prophylactic applications are limited
by the low bioavailability caused by its physical properties.
Additionally, resveratrol has low water solubility and stabi-
lity making its clinical success a formidable technological
and medical challenge. The aim of this work is to present
results of improvement of solubility of resveratrol through
micellar and liposomal incorporation.
Methods
Solubilization of resveratrol in six different bile acid solu-
tions (cholic acid and its keto derivates) was investigated
after 18 hours of mixing 2 mg of resveratrol in 2 ml of
bile acid solutions in pH 7 buffer at room temperature.
Liposome preparations containing pure resveratrol,
resveratrol with vitamin C and resveratrol with vitamin E
were prepared using the thin film hydration method.
Resveratrol content was analyzed using HPLC with
UV/DAD detection.
Results
The analysis of solubilization of resveratrol showed that
keto derivatives of cholic acid have greater ability to
solubilize resveratrol than cholic acid, and that this effi-
ciency increases with the number of keto groups present
in bile acid. The most effective acid for the solubiliza-
tion of resveratrol was 3,7,12-triketocholic acid. Also, it
has been shown that the efficiency of incorporation of
resveratrol in liposomes increases with the amount of
added resveratrol during preparation and the presence
of vitamin C or E in the formulation, and that these pre-
parations have satisfactory characteristics.
Conclusions
Experiments carried out in this study provide useful
information for potential development of different diet-
ary and pharmaceutical resveratrol products.
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